Ascorbyl palmitate (ASC16) as a potential inhibitor of toxicity induced by Crotalus durissus terrificus venom
Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology · 2024
DOI: 10.1016/j.cbpc.2024.109973 ↗Kurz gefasst
Fachartikel in der Zeitschrift Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 2024. Verfasst von Franco Maslovski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de Química Básica y Aplicada del Nordeste Argentino (IQUIBA-NEA), W34…. Hauptthemen laut MEDLINE: Crotalus, Crotoxin, Venomous Snakes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: CONICET, Universidad Nacional del Nordeste.
Abstract (Originalsprache)
It is well known that C. d. terrificus venom causes pathophysiological effects such as neuropathies, coagulopathies, and even death. Previous studies have reported that ASC16 can interact with monomeric phospholipases A2 from the venom of various snake species (e.g., Vipera russelli and Echis carinatus). As a result, ASC16 has been proposed as an inhibitor of the toxic effects induced by the heterodimeric complex (crotoxin) and other components of the venom of C. d. terrificus. To investigate this further, in silico studies were designed using the crotoxin (CTX) protein complex as a model, and experimental assays were conducted to evaluate the inhibitory effect of ASC16 on CTX, as well as on other venom enzymes such as thrombin-like enzyme (TLE), phosphodiesterase (PDE) and l-aminoxidase (LAAO). For in vitro assays, specific substrates were used, and lethal activity was measured over 48 h using an in vivo murine experimental model (CF01). In silico studies have indicated that the hydrophilic portion of ASC16 adopts a stable conformation while interacting with the catalytic site of crotoxin. At the highest concentrations, ASC16 significantly inhibited the activities of PLA2 (40.89 ± 0.09 %), TLE (11.03 ± 0.69 %), PDE (51.33 ± 2.83 %), and LAAO (56.79 ± 2.91 %). Furthermore, ASC16 neutralized the 2 LD50 lethality of crotalic venom. These findings lay the groundwork for designing promising adjuvants that can facilitate the incorporation of a larger quantity of proteins in immunization schemes. Consequently, this approach aims to achieve higher antibody titers, reduce the number of required immunizations, and minimize local damage in the producer animal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Instituto de Química Básica y Aplicada del Nordeste Argentino (IQUIBA-NEA), W3404AAS Corrientes, Argentina; Facultad de Ciencias Exactas y Naturales…
Förderung
- CONICET
- Universidad Nacional del Nordeste
Zitieren
APA
Maslovski, F., Angelina, E., Alonso, M., Leiva, L., & Fusco, L. (2024). Ascorbyl palmitate (ASC16) as a potential inhibitor of toxicity induced by Crotalus durissus terrificus venom. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology. https://doi.org/10.1016/j.cbpc.2024.109973
Vancouver
Maslovski F, Angelina E, Alonso M, Leiva L, Fusco L. Ascorbyl palmitate (ASC16) as a potential inhibitor of toxicity induced by Crotalus durissus terrificus venom. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology. 2024. doi:10.1016/j.cbpc.2024.109973
BibTeX
@article{Maslovski2024,
author = {Maslovski, Franco and Angelina, Emilio and Alonso, María and Leiva, Laura and Fusco, Luciano},
title = {Ascorbyl palmitate (ASC16) as a potential inhibitor of toxicity induced by Crotalus durissus terrificus venom},
journal = {Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology},
year = {2024},
doi = {10.1016/j.cbpc.2024.109973}
}
EUVIMED